HEATHER MULLER: Open Payments
NPI 1821772104 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 9 payments from 8 companies in 2025. Trend: 2023 $124 · 2024 $23 · 2025 $825
Food & beverage: $825
| Company | Payments | Amount |
|---|---|---|
| CeQur Corporation | 1 | $150 |
| Insulet Corporation | 1 | $150 |
| BETA BIONICS, INC. | 1 | $138 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $117 |
| Novo Nordisk Inc | 1 | $105 |
| Amgen Inc. | 1 | $100 |
| Tandem Diabetes Care, Inc. | 2 | $42 |
| Lilly USA, LLC | 1 | $23 |
Products named: CeQur Simplicity, Omnipod, iLet Bionic Pancreas, Kerendia, Ozempic, EVENITY, t:slim X2 Insulin Pump with Control-IQ, MOUNJARO.
Industry payments across PA — which companies pay providers there.
